Title:
SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/018046
Kind Code:
A1
Abstract:
A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.
Inventors:
MAO QINGHUA (CN)
YU TAO (CN)
LI YI (CN)
WU CHENGDE (CN)
CHEN SHUHUI (CN)
YU TAO (CN)
LI YI (CN)
WU CHENGDE (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2020/104534
Publication Date:
February 04, 2021
Filing Date:
July 24, 2020
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
A61K31/395; A61K31/4155; C07D401/14; C07D405/14; C07D413/14
Domestic Patent References:
WO2005092877A1 | 2005-10-06 | |||
WO2007093610A1 | 2007-08-23 | |||
WO2006064033A2 | 2006-06-22 | |||
WO2008020011A1 | 2008-02-21 | |||
WO2008109591A1 | 2008-09-12 | |||
WO2008055940A2 | 2008-05-15 | |||
WO2008042688A2 | 2008-04-10 | |||
WO2012094293A1 | 2012-07-12 |
Foreign References:
CN105294694A | 2016-02-03 | |||
CN201910683107A | 2019-07-26 | |||
CN202010105252A | 2020-02-20 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: